AIP Takes Avanos Medical Private in $1.27 Billion Deal
Event summary
- American Industrial Partners (AIP) completed its acquisition of Avanos Medical for $1.27 billion, delisting the company from the NYSE.
- Avanos shareholders received $25 per share in cash under the terms of the merger agreement.
- AIP plans to leverage operational expertise to accelerate Avanos's innovation roadmap and long-term growth.
- Avanos CEO Dave Pacitti emphasized the partnership with AIP will enable faster execution on existing initiatives.
The big picture
AIP's acquisition of Avanos Medical underscores the private equity firm's focus on operationally oriented investments in the industrials sector. With $17.8 billion in assets under management and a portfolio generating $32 billion in annual revenues, AIP is positioning Avanos for long-term growth by leveraging its deep operational expertise. This deal reflects broader trends of private equity firms targeting established medical technology companies to drive innovation and value creation through strategic operational interventions.
What we're watching
- Operational Execution
- How AIP's operational agenda will translate into tangible growth for Avanos, particularly in innovation and market expansion.
- Private Equity Strategy
- Whether AIP can sustain the momentum of Avanos under private ownership, given its track record with similar investments.
- Market Positioning
- The pace at which Avanos can solidify its leading market positions in key medical device categories post-acquisition.
Related topics